OPERATION WARP SPEED

COVID-19 RESPONSE OPERATION

When the federal government unveiled Operation Warp Speed (OWS) in May 2020, it was “unlike anything our country has seen since the Manhattan Project.” The multi-agency initiative’s central goal - to develop, produce, and distribute 300 million doses of a safe and effective coronavirus vaccine by January 2021 - requires a deep knowledge of science and how to manage complex government operations while navigating a challenging pandemic.

In this Case Study, you will find:

• Benefits of working with military populations in clinical trials
• Map of military treatment facilities Geneva is working with to advance Operation Warp Speed
• Timeline of clinical trials
• Regulatory expertise
• Types of positions needed to support OWS

Geneva is proud to have over 25 years of experience in delivering full-spectrum scientific, technical, and program management expertise in the areas of federal contracts, federal grants, and industry-sponsored clinical trials.

Geneva is a 501(c)3 non-profit organization that advances military medicine through innovative scientific research, exceptional program management, and a dedication to U.S. service members and veterans, their families, and the global community.